Current position:Home >Product >
nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate(93919-68-7)
- Name: nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
- Synonyms:EINECS 300-051-1;Nonapotassium hydrogen (((phosphonomethyl)imino)bis(ethane-2,1-diylnitrilobis(methylene)))tetrakisphosphonate;
- Molecular Formula:C9H28 N3 O15 P5 . 9 K
- Molecular Weight:917.0192
- CAS Registry Number:93919-68-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.93919-68-7 Phosphonic acid,[[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-,nonapotassium salt (9CI)
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.93919-68-7 Nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 6764-27-8/sodium 2-[4-(2-cyanoacetamido)phenyl]-6-methylbenzothiazole-7-sulphonate
- 5664-29-9/AMINO-CYCLOHEXYL-ACETIC ACID
- 81053-69-2/4-[(1E)-3-methyl-3-(4-methylbenzyl)triaz-1-en-1-yl]benzonitrile
- 67237-80-3/2-{[2-(3,4-dimethoxyphenyl)-1,3-dioxolan-2-yl]methyl}benzonitrile
- 169312-06-5/b-D-Glucopyranoside,4-[(1R,2R)-1,3-dihydroxy-2-[4-[(1E)-3-hydroxy-1-propenyl]-2,6-dimethoxyphenoxy]propyl]-2,6-dimethoxyphenyl(9CI)
- 13401-56-4/3-Chloro-2,2-dimethyl-1-propanol
- 62832-08-0/N,N-dimethyl-2-{[4-(4-methylphenyl)-1-phenyl-1H-pyrazol-3-yl]oxy}ethanamine hydrochloride
- 87776-99-6/(2E)-7-(3-acetyl-1,3-oxazolidin-2-yl)-2,6-dimethylhept-2-en-1-ol
- 149488-39-1/1-[2-(2-ethoxy-6-fluorophenyl)ethyl]-3-(5-methylpyridin-2-yl)thiourea
- 94158-79-9/2,7-Naphthalenedisulfonicacid,4,4'-[(6-chloro-1,3,5-triazine-2,4-diyl)diimino]bis[5-hydroxy-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-,sodium salt (9CI)
- 104612-36-4/5-Bromo-2-hydroxynicotinic acid
- 15258-55-6/2,3,4-TRIMETHOXYBENZALDEHYDE OXIME
- 112059-04-8/6-benzyl-2-chloro-1-methylchromeno[2,3-b][1,5]benzodiazepin-13(6H)-one
- 209856-24-6/1-71-Complement C5a[1-methionine,27-serine,71-cysteine] (human), dimer
- 118002-46-3/L-Cysteine,N-[(1,1-dimethylethoxy)carbonyl]-L-cysteinylglycyl-L-prolylglycyl-L-prolyl-,diphenylmethyl ester, cyclic (1®6)-disulfide (9CI)
- 76341-55-4/2-methyl-5,6-di(pyridin-2-yl)-2,3-dihydropyrazine
- 154977-75-0/b-D-Glucopyranosiduronic acid, (3b,4a,16b,21b,22a)-21,23,28-trihydroxy-16,22-bis[[(2E)-2-methyl-1-oxo-2-butenyl]oxy]olean-12-en-3-yl(9CI)
- 91051-62-6/Fatty acids, tall-oil,1,4-butanediyl esters
- 328569-19-3/1,3-Benzenedicarboxylicacid, 5-hydroxy-, polymers with 3-(4-aminophenoxy)benzenamine,3-carboxy-1-cyano-1-methylpropyl-terminated acrylonitrile-butadiene polymer andisophthalic acid
- 93919-68-7/nonapotassium hydrogen [[(phosphonomethyl)imino]bis[ethane-2,1-diylnitrilobis(methylene)]]tetrakisphosphonate
- 28515-57-3/methylenedinaphthalene
- 6487-30-5/6-Isoquinolinol,1-[[(2S,3R,11bS)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-yl]methyl]-1,2,3,4-tetrahydro-7-methoxy-,hydrochloride, hydrate (1:2:7), (1R)-
- 208466-18-6/3-Hexulose,2,6-anhydro-1-deoxy-6-C-(1-hydroxy-10,12-dimethoxy-8-methyl-6-oxo-6H-benzo[d]naphtho[1,2-b]pyran-4-yl)-4-C-methyl-
- 811-07-4/4-{1,3-bis[4-(dimethylamino)benzyl]hexahydropyrimidin-2-yl}-N,N-bis(2-chloroethyl)-3-methylaniline
- 62883-64-1/Benzoxazolium,3-ethyl-5-phenyl-2-[3-[5-phenyl-3-[2-(sulfooxy)ethyl]-2(3H)-benzothiazolylidene]-1-propen-1-yl]-,inner salt
- 13183-58-9/1-[(methylsulfinyl)methyl]naphthalene
- 33755-64-5/hexa-1,3,4-triene
- 70695-35-1/Piperidine,1-(2-phenyl-1,3-dioxan-5-yl)-, hydrochloride (1:1)
- 90530-32-8/2-Propenoic acid, reaction products with ethylenediamine, sodium salts
- 103889-86-7/(S)-AMINO-(2-METHOXY-PHENYL)-ACETIC ACID